Filtros

Buscador
Año
Barcia C., Ros C.M., Ros-Bernal F., Gómez A., Annese V., Carrillo-de Sauvage M.A., Yuste J.E., Campuzano C.M., de Pablos V., Fernández-Villalba E., Herrero M.T. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term parkinsonian macaques. Journal of Neuroimmunology. 15 August 2013. 261:60-66. 10.1016/j.jneuroim.2013.05.001
AÑO: 2013; IF: 2.786
Annese V., Barcia C., Ros-Bernal F., Gómez A., Ros C.M., De Pablos V., Fernández-Villalba E., De Stefano M.E., Herrero M.T. Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism. Neuropathology and Applied Neurobiology. February 2013. 39:132-143. 10.1111/j.1365-2990.2012.01271.x
AÑO: 2013; IF: 4.97
Carrillo-De Sauvage M.A., Maatouk L., Arnoux I., Pasco M., Sanz Diez A., Delahaye M., Herrero M.T., Newman T.A., Calvo C.F., Audinat E., Tronche F., Vyas S. Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation. Cell Death and Differentiation. November 2013. 20:1546-1557. 10.1038/cdd.2013.108
AÑO: 2013; IF: 8.385
Campello L., Esteve-Rudd J., Bru-Martínez R., Herrero M.T., Fernández-Villalba E., Cuenca N., Martín-Nieto J. Alterations in Energy Metabolism, Neuroprotection and Visual Signal Transduction in the Retina of Parkinsonian, MPTP-Treated Monkeys. Plos One. 5 September 2013. 8. 10.1371/journal.pone.0074439
AÑO: 2013; IF: 3.534
Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin O, Tarragon E, Bordet R. Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans. Drug Discov Today Technol. 2013 Sep;10(3):e329-42. Review. PubMed PMID: 24179995.
AÑO: 2013